Importantly, a prospective study shows that the elevation of systemic chemerin precedes the onset of T2DM (Bobbert et al. 2015), suggesting that chemerin could serve as a biomarker for early diagnosis of T2DM. This evidence concerns the gene RARRES2 and type 2 diabetes mellitus.